Article

Harnessing molecular mechanism for precision medicine in dilated cardiomyopathy caused by a mutation in troponin T

2024-04-09

Abstract excerpt

Familial dilated cardiomyopathy (DCM) is frequently caused by autosomal dominant point mutations in genes involved in diverse cellular processes, including sarcomeric contraction. While patient studies have defined the genetic landscape of DCM, genetics are not currently used in patient care, and patients receive similar treatments regardless of the underlying mutation. It has been suggested that a precision medic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9ab04b32-54f3-561b-ac3b-ceb8fbf6dd4c
DOI: 10.1101/2024.04.05.588306

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Harnessing molecular mechanism for precision medicine in dilated cardiomyopathy caused by a mutation in troponin TDOI 10.1101/2024.04.05.588306Read

Disrupted Mechanobiology Links the Molecular and Cellular Phenotypes in Familial Dilated CardiomyopathySemantic proximity Read

Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathySemantic proximity Read

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy.Semantic proximity Read

Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine.Semantic proximity Read

Human iPSC-CMs and in-silico technologies define mechanisms and accelerate targeted pharmacogenetics in hypertrophic cardiomyopathySemantic proximity Read

Mechanical dysfunction induced by a hypertrophic cardiomyopathy mutation is the primary driver of cellular adaptationSemantic proximity Read

Signaling network model of cardiomyocyte morphological changes in familial cardiomyopathySemantic proximity Read

Distinct mechanisms drive divergent phenotypes in hypertrophic and dilated cardiomyopathy-associated TPM1 variants.Semantic proximity Read

Mechanical dysfunction of the sarcomere induced by a pathogenic mutation in troponin T drives cellular adaptation.Semantic proximity Read

Structural and Phenotypic Correction of K210del Genetic Cardiomyopathy by an FDA Approved DrugSemantic proximity Read

Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca2+, and activate NFAT and Akt signaling.Semantic proximity Read

Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases.Semantic proximity Read